• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heterogeneity in active surveillance protocols worldwide.

作者信息

Loeb Stacy, Carter H Ballentine, Schwartz Mark, Fagerlin Angela, Braithwaite R Scott, Lepor Herbert

机构信息

The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD.

Population Health, New York University, New York, NY.

出版信息

Rev Urol. 2014;16(4):202-3.

PMID:25548550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4274180/
Abstract
摘要

相似文献

1
Heterogeneity in active surveillance protocols worldwide.全球主动监测方案的异质性。
Rev Urol. 2014;16(4):202-3.
2
Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative.坚持低危前列腺癌的主动监测方案：莫菲特基金会全球行动计划前列腺癌主动监测倡议的结果。
Eur Urol Oncol. 2020 Feb;3(1):80-91. doi: 10.1016/j.euo.2019.08.014. Epub 2019 Sep 26.
3
Pathological outcome for Chinese patients with low-risk prostate cancer eligible for active surveillance and undergoing radical prostatectomy: comparison of six different active surveillance protocols.适合积极监测并接受根治性前列腺切除术的中国低风险前列腺癌患者的病理结果：六种不同积极监测方案的比较
Hong Kong Med J. 2017 Dec;23(6):609-15. doi: 10.12809/hkmj166194. Epub 2017 Oct 13.
4
Comparison of pathological outcomes of active surveillance candidates who underwent radical prostatectomy using contemporary protocols at a high-volume Korean center.在韩国一家高容量中心，采用当代方案对接受根治性前列腺切除术的主动监测候选者的病理结果进行比较。
Jpn J Clin Oncol. 2012 Nov;42(11):1079-85. doi: 10.1093/jjco/hys147. Epub 2012 Sep 17.
5
Active surveillance for prostate cancer: can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?前列腺癌的主动监测：在聚焦治疗时代，我们能否改进当代方案以优化患者选择并改善治疗结果？
Curr Opin Urol. 2015 May;25(3):185-90. doi: 10.1097/MOU.0000000000000168.
6
A first step towards a global nomogram to predict disease progression for men on active surveillance.迈向全球列线图以预测接受主动监测的男性疾病进展的第一步。
Transl Androl Urol. 2021 Mar;10(3):1102-1109. doi: 10.21037/tau-20-1082.
7
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.对临床局限性前列腺癌主动监测的系统评价，以制定关于纳入中危疾病、纳入时的活检特征及监测以及监测重复活检策略的建议。
Eur Urol. 2022 Apr;81(4):337-346. doi: 10.1016/j.eururo.2021.12.007. Epub 2021 Dec 31.
8
Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices.前列腺癌的主动监测：当代全球实践的系统评价
Transl Androl Urol. 2018 Feb;7(1):83-97. doi: 10.21037/tau.2017.12.24.
9
Surveillance for low-risk kidney cancer: a narrative review of contemporary worldwide practices.低风险肾癌的监测：当代全球实践的叙述性综述
Transl Androl Urol. 2021 Jun;10(6):2762-2786. doi: 10.21037/tau-20-1295.
10
Stricter Active Surveillance Criteria for Prostate Cancer do Not Result in Significantly Better Outcomes: A Comparison of Contemporary Protocols.更严格的前列腺癌主动监测标准并未带来显著更好的结果：对当代方案的比较。
J Urol. 2016 Dec;196(6):1645-1650. doi: 10.1016/j.juro.2016.06.083. Epub 2016 Jun 24.

引用本文的文献

1
AI-generated questions for urological competency assessment: a prospective educational study.用于泌尿外科能力评估的人工智能生成问题：一项前瞻性教育研究。
BMC Med Educ. 2025 Apr 25;25(1):611. doi: 10.1186/s12909-025-07202-x.
2
Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit.使用个性化时间表进行有负担的监测测试的共同决策及其负担和益处。
Stat Med. 2022 May 30;41(12):2115-2131. doi: 10.1002/sim.9347. Epub 2022 Feb 10.
3
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance.基于低危前列腺癌主动监测患者 Gleason 升级风险的个体化活检方案。
BJU Int. 2021 Jan;127(1):96-107. doi: 10.1111/bju.15136. Epub 2020 Aug 1.
4
Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs.前列腺癌主动监测项目中活检的个性化决策制定。
Med Decis Making. 2019 Jul;39(5):499-508. doi: 10.1177/0272989X19861963. Epub 2019 Jul 18.
5
Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.多参数磁共振成像与前列腺癌主动监测中医疗保险支出增加相关。
Eur Urol Focus. 2020 Mar 15;6(2):242-248. doi: 10.1016/j.euf.2019.04.008. Epub 2019 Apr 25.
6
Biomarkers in active surveillance.主动监测中的生物标志物。
Transl Androl Urol. 2018 Feb;7(1):155-159. doi: 10.21037/tau.2017.12.26.
7
Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.主动监测与观察等待对局限性前列腺癌的比较：一种辅助决策的模型。
Eur Urol. 2017 Dec;72(6):899-907. doi: 10.1016/j.eururo.2017.07.018. Epub 2017 Aug 23.
8
Qualitative study on decision-making by prostate cancer physicians during active surveillance.前列腺癌医生在主动监测期间决策的定性研究
BJU Int. 2017 Jul;120(1):32-39. doi: 10.1111/bju.13651. Epub 2016 Oct 2.

本文引用的文献

1
Active surveillance for low-risk prostate cancer: diversity of practice across Europe.低风险前列腺癌的主动监测：欧洲各地的实践差异
Ir J Med Sci. 2015 Jun;184(2):305-11. doi: 10.1007/s11845-014-1104-5. Epub 2014 Mar 21.
2
The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort.基线 [-2]proPSA 相关指标对低危前列腺癌主动监测 1 年内病理重新分类预测的影响：日本多中心研究队列。
J Cancer Res Clin Oncol. 2014 Feb;140(2):257-63. doi: 10.1007/s00432-013-1566-2. Epub 2013 Dec 19.
3
Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.基于人群的研究：低危和中危前列腺癌采用主动监测和观察等待的使用情况及其决定因素。
J Urol. 2013 Nov;190(5):1742-9. doi: 10.1016/j.juro.2013.05.054. Epub 2013 May 30.
4
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.主动监测队列中的尿 TMPRSS2:ERG 和 PCA3：Canary 前列腺主动监测研究中的基线分析结果。
Clin Cancer Res. 2013 May 1;19(9):2442-50. doi: 10.1158/1078-0432.CCR-12-3283. Epub 2013 Mar 20.
5
Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.游离前列腺特异性抗原 -2 与前列腺癌主动监测中活检再分类的相关性。
J Urol. 2012 Oct;188(4):1131-6. doi: 10.1016/j.juro.2012.06.009. Epub 2012 Aug 15.
6
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer.美国国立卫生研究院现状科学会议：主动监测在局限性前列腺癌男性管理中的作用。
Ann Intern Med. 2012 Apr 17;156(8):591-5. doi: 10.7326/0003-4819-156-8-201204170-00401. Epub 2012 Feb 20.
7
Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists.主动监测低危前列腺癌：泌尿科医生的知识、接受度和实践。
Prostate Cancer Prostatic Dis. 2012 Jun;15(2):177-81. doi: 10.1038/pcan.2011.57. Epub 2011 Dec 6.
8
Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program.PCA3 测量在主动监测方案中预测短期活检进展的准确性。
J Urol. 2010 Feb;183(2):534-8. doi: 10.1016/j.juro.2009.10.003. Epub 2009 Dec 14.